Today's pre-market stock movers: GME, NIO, XPEV, BB and more

• $GameStop (GME.US)$ +14.16% (to seek approval for 3.33-for-l stock split)

• $Sage Therapeutics (SAGE.US)$ +5.7% (announces presentation of promising results from the Phase 2 LUMINARY Study of SAGE-718 in patients with mild cognitive impairment and mild dementia due to Alzheimer's Disease)

• $Baozun (BZUN.US)$ +6% (announces repurchase right notification for 1.625% Convertible Senior Notes due 2024)

• $XPeng (XPEV.US)$ +8.9% (announces vehicle delivery results for march and first quarter 2022; 34561 vehicles delivered in QI 2022 a 159% increase yr/yr)

• $NIO Inc (NIO.US)$ +6.27% (provides March and Q1 delivery update)

• $Li Auto (LI.US)$ +5.7% (reports March deliveries increased 125.2% yr/yr)

• $Pharming Group (PHAR.US)$ +5.7% (positive data from Phase II/III leniolisib trial presented)

• $Clene (CLNN.US)$ +5.6% (along with its subsidiaries "Clene" and its wholly owned subsidiary Clene Nanomedicine announce new data from the open-label extension of RESCUE-ALS)

• $Kosmos Energy (KOS.US)$ +4.6% (successfully refinances credit facility)

• $Fisker (FSR.US)$ +3.1% (passes 40000 initial reservations for Fisker Ocean SUV)

• $The Lion Electric (LEV.US)$ +3% (receives purchase order for 30 school buses)

• $Robinhood (HOOD.US)$ +1.7% (nearing launch of retirement account support on its platform according to Bloomberg)

• $Tellurian (TELL.US)$ +7.2% (upgraded to Outperform from Neutral at Credit Suisse)

• $Redwire (RDW.US)$ -19.2%, $Blend Labs (BLND.US)$ -17.54%, $Duck Creek Technologies (DCT.US)$ -12.97%, $BlackBerry (BB.US)$ -4.8%

• $Sellas Life Sciences (SLS.US)$ -22.5% (signs license agreement with GenFleet Therapeutics for GFH009; prices offering of 4629630 shares of its common stock and accompanying warrants to purchase up to 4629630 shares of common stock at a combined public offering price of $5.40 per share and accompanying warrant)

• $Spero Therapeutics (SPRO.US)$ -19.5% (FDA identifies deficiencies in Spero's NDA for tebipenem)

• $ALLETE (ALE.US)$ -5.6% (prices offering of 3.2 mln shares of common stock at $63.00 per share)

• $Innovative Industrial Properties Inc (IIPR.US)$ -3.6% (commences public offering of 1 mln shares)

• $Amylyx Pharmaceuticals (AMLX.US)$ -3.4% (downgraded to Neutral from Buy at Goldman)

• $Wayfair (W.US)$ -2.5% (downgraded to Underweight from Equal Weight at Barclays)

• $CommScope (COMM.US)$ -2.3% (downgraded to Neutral from Buy at Goldman)